Buscar
Mostrando ítems 1-10 de 47
Development of fast and simple chromogenic methods for glucan phosphatases in-gel activity assays
(Academic Press Inc Elsevier Science, 2017-01)
Glucan phosphatases are essential for normal starch degradation in plants and glycogen metabolism in mammals. Here we develop two chromogenic methods for the detection of glucan phosphatase activity in situ after non ...
Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas
(Associação Brasileira de Divulgação Científica (ABRADIC), 2013-03-19)
Human epidermal growth factor receptor 2 (HER2) has been evaluated in breast cancer patients to identify those most likely to benefit from herceptin-targeted therapy. HER2 amplification, detected in 20-30% of invasive ...
Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas
(Associação Brasileira de Divulgação Científica (ABRADIC), 2013-03-19)
Human epidermal growth factor receptor 2 (HER2) has been evaluated in breast cancer patients to identify those most likely to benefit from herceptin-targeted therapy. HER2 amplification, detected in 20-30% of invasive ...
Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas
(Associação Brasileira de Divulgação Científica (ABRADIC), 2014)
Evaluation of MYC Gene Amplification in Prostate Cancer Using a Dual Color Chromogenic In Situ Hybridization (Dual CISH) Assay
(Publishing Company in Wilmington, 2013)
Evaluación de la amplificación del oncogén HER2 en pacientes con cáncer de mama a través de la técnica de hibridación in situ cromogénica (CISH)
(Universidad de Carabobo, 2014-04)
El protooncogén
HER2
se encuentra localizado en el cromosoma
17. Codifica una glicoproteína transmembrana llamada receptor
del factor de crecimiento epidérmico humano 2 (HER2). Está
amplificado a bajos ...
Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma
(Biomed Central Ltd., 2009-03-23)
Background: HER-2 gene testing has become an integral part of breast cancer patient diagnosis. The most commonly used assay in the clinical setting for evaluating HER-2 status is immunohistochemistry (IHC) and fluorescence ...
Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma
(Biomed Central Ltd., 2009-03-23)
Background: HER-2 gene testing has become an integral part of breast cancer patient diagnosis. The most commonly used assay in the clinical setting for evaluating HER-2 status is immunohistochemistry (IHC) and fluorescence ...